Abstract
Summary
The global BANK1 Antibody market size is projected to grow from US$ million in 2024 to US$ million in 2031; it is expected to grow at a CAGR of % from 2025 to 2031.
Growing patient base, launch of novel HMGB1 antibody drugs, increasing penetration of antibody drugs, and continuous regulation across the biopharmaceutical industry are the key factors driving the increase in BANK1 antibody market revenue.
The protein encoded by this gene is a B-cell-specific scaffold protein that functions in B-cell receptor-induced calcium mobilization from intracellular stores. This protein can also promote Lyn-mediated tyrosine phosphorylation of inositol 1,4,5-trisphosphate receptors. Polymorphisms in this gene are associated with susceptibility to systemic lupus erythematosus.
LPI (LP Information)' newest research report, the “BANK1 Antibody Industry Forecast” looks at past sales and reviews total world BANK1 Antibody sales in 2024, providing a comprehensive analysis by region and market sector of projected BANK1 Antibody sales for 2025 through 2031. With BANK1 Antibody sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world BANK1 Antibody industry.
This Insight Report provides a comprehensive analysis of the global BANK1 Antibody landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on BANK1 Antibody portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global BANK1 Antibody market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for BANK1 Antibody and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global BANK1 Antibody.
This report presents a comprehensive overview, market shares, and growth opportunities of BANK1 Antibody market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Monoclonal
Polyclonal
Segmentation by application
Immunochemistry (IHC)
Immunofluorescence (IF)
Immunoprecipitation (IP)
Western Blot (WB)
ELISA
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
Merck
BosterBio
LifeSpan BioSciences
GeneTex
Leading Biology
RayBiotech
ProSci
Novus Biologicals
ABclonal Technology
R and D Systems
United States Biological
Santa Cruz Biotechnology
Biobyt
Beijing Solarbio
Jingjie PTM BioLab
Growing patient base, launch of novel HMGB1 antibody drugs, increasing penetration of antibody drugs, and continuous regulation across the biopharmaceutical industry are the key factors driving the increase in BANK1 antibody market revenue.
The protein encoded by this gene is a B-cell-specific scaffold protein that functions in B-cell receptor-induced calcium mobilization from intracellular stores. This protein can also promote Lyn-mediated tyrosine phosphorylation of inositol 1,4,5-trisphosphate receptors. Polymorphisms in this gene are associated with susceptibility to systemic lupus erythematosus.
LPI (LP Information)' newest research report, the “BANK1 Antibody Industry Forecast” looks at past sales and reviews total world BANK1 Antibody sales in 2024, providing a comprehensive analysis by region and market sector of projected BANK1 Antibody sales for 2025 through 2031. With BANK1 Antibody sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world BANK1 Antibody industry.
This Insight Report provides a comprehensive analysis of the global BANK1 Antibody landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on BANK1 Antibody portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global BANK1 Antibody market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for BANK1 Antibody and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global BANK1 Antibody.
This report presents a comprehensive overview, market shares, and growth opportunities of BANK1 Antibody market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Monoclonal
Polyclonal
Segmentation by application
Immunochemistry (IHC)
Immunofluorescence (IF)
Immunoprecipitation (IP)
Western Blot (WB)
ELISA
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
Merck
BosterBio
LifeSpan BioSciences
GeneTex
Leading Biology
RayBiotech
ProSci
Novus Biologicals
ABclonal Technology
R and D Systems
United States Biological
Santa Cruz Biotechnology
Biobyt
Beijing Solarbio
Jingjie PTM BioLab
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global BANK1 Antibody Market Size 2020-2031
2.1.2 BANK1 Antibody Market Size CAGR by Region 2020 VS 2024 VS 2031
2.2 BANK1 Antibody Segment by Type
2.2.1 Monoclonal
2.2.2 Polyclonal
2.3 BANK1 Antibody Market Size by Type
2.3.1 BANK1 Antibody Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global BANK1 Antibody Market Size Market Share by Type (2020-2025)
2.4 BANK1 Antibody Segment by Application
2.4.1 Immunochemistry (IHC)
2.4.2 Immunofluorescence (IF)
2.4.3 Immunoprecipitation (IP)
2.4.4 Western Blot (WB)
2.4.5 ELISA
2.4.6 Others
2.5 BANK1 Antibody Market Size by Application
2.5.1 BANK1 Antibody Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global BANK1 Antibody Market Size Market Share by Application (2020-2025)
3 BANK1 Antibody Market Size by Player
3.1 BANK1 Antibody Market Size Market Share by Players
3.1.1 Global BANK1 Antibody Revenue by Players (2020-2025)
3.1.2 Global BANK1 Antibody Revenue Market Share by Players (2020-2025)
3.2 Global BANK1 Antibody Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 BANK1 Antibody by Regions
4.1 BANK1 Antibody Market Size by Regions (2020-2025)
4.2 Americas BANK1 Antibody Market Size Growth (2020-2025)
4.3 APAC BANK1 Antibody Market Size Growth (2020-2025)
4.4 Europe BANK1 Antibody Market Size Growth (2020-2025)
4.5 Middle East & Africa BANK1 Antibody Market Size Growth (2020-2025)
5 Americas
5.1 Americas BANK1 Antibody Market Size by Country (2020-2025)
5.2 Americas BANK1 Antibody Market Size by Type (2020-2025)
5.3 Americas BANK1 Antibody Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC BANK1 Antibody Market Size by Region (2020-2025)
6.2 APAC BANK1 Antibody Market Size by Type (2020-2025)
6.3 APAC BANK1 Antibody Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe BANK1 Antibody by Country (2020-2025)
7.2 Europe BANK1 Antibody Market Size by Type (2020-2025)
7.3 Europe BANK1 Antibody Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa BANK1 Antibody by Region (2020-2025)
8.2 Middle East & Africa BANK1 Antibody Market Size by Type (2020-2025)
8.3 Middle East & Africa BANK1 Antibody Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global BANK1 Antibody Market Forecast
10.1 Global BANK1 Antibody Forecast by Regions (2026-2031)
10.1.1 Global BANK1 Antibody Forecast by Regions (2026-2031)
10.1.2 Americas BANK1 Antibody Forecast
10.1.3 APAC BANK1 Antibody Forecast
10.1.4 Europe BANK1 Antibody Forecast
10.1.5 Middle East & Africa BANK1 Antibody Forecast
10.2 Americas BANK1 Antibody Forecast by Country (2026-2031)
10.2.1 United States BANK1 Antibody Market Forecast
10.2.2 Canada BANK1 Antibody Market Forecast
10.2.3 Mexico BANK1 Antibody Market Forecast
10.2.4 Brazil BANK1 Antibody Market Forecast
10.3 APAC BANK1 Antibody Forecast by Region (2026-2031)
10.3.1 China BANK1 Antibody Market Forecast
10.3.2 Japan BANK1 Antibody Market Forecast
10.3.3 Korea BANK1 Antibody Market Forecast
10.3.4 Southeast Asia BANK1 Antibody Market Forecast
10.3.5 India BANK1 Antibody Market Forecast
10.3.6 Australia BANK1 Antibody Market Forecast
10.4 Europe BANK1 Antibody Forecast by Country (2026-2031)
10.4.1 Germany BANK1 Antibody Market Forecast
10.4.2 France BANK1 Antibody Market Forecast
10.4.3 UK BANK1 Antibody Market Forecast
10.4.4 Italy BANK1 Antibody Market Forecast
10.4.5 Russia BANK1 Antibody Market Forecast
10.5 Middle East & Africa BANK1 Antibody Forecast by Region (2026-2031)
10.5.1 Egypt BANK1 Antibody Market Forecast
10.5.2 South Africa BANK1 Antibody Market Forecast
10.5.3 Israel BANK1 Antibody Market Forecast
10.5.4 Turkey BANK1 Antibody Market Forecast
10.5.5 GCC Countries BANK1 Antibody Market Forecast
10.6 Global BANK1 Antibody Forecast by Type (2026-2031)
10.7 Global BANK1 Antibody Forecast by Application (2026-2031)
11 Key Players Analysis
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Information
11.1.2 Thermo Fisher Scientific BANK1 Antibody Product Offered
11.1.3 Thermo Fisher Scientific BANK1 Antibody Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Thermo Fisher Scientific Main Business Overview
11.1.5 Thermo Fisher Scientific Latest Developments
11.2 Merck
11.2.1 Merck Company Information
11.2.2 Merck BANK1 Antibody Product Offered
11.2.3 Merck BANK1 Antibody Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Merck Main Business Overview
11.2.5 Merck Latest Developments
11.3 BosterBio
11.3.1 BosterBio Company Information
11.3.2 BosterBio BANK1 Antibody Product Offered
11.3.3 BosterBio BANK1 Antibody Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 BosterBio Main Business Overview
11.3.5 BosterBio Latest Developments
11.4 LifeSpan BioSciences
11.4.1 LifeSpan BioSciences Company Information
11.4.2 LifeSpan BioSciences BANK1 Antibody Product Offered
11.4.3 LifeSpan BioSciences BANK1 Antibody Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 LifeSpan BioSciences Main Business Overview
11.4.5 LifeSpan BioSciences Latest Developments
11.5 GeneTex
11.5.1 GeneTex Company Information
11.5.2 GeneTex BANK1 Antibody Product Offered
11.5.3 GeneTex BANK1 Antibody Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 GeneTex Main Business Overview
11.5.5 GeneTex Latest Developments
11.6 Leading Biology
11.6.1 Leading Biology Company Information
11.6.2 Leading Biology BANK1 Antibody Product Offered
11.6.3 Leading Biology BANK1 Antibody Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Leading Biology Main Business Overview
11.6.5 Leading Biology Latest Developments
11.7 RayBiotech
11.7.1 RayBiotech Company Information
11.7.2 RayBiotech BANK1 Antibody Product Offered
11.7.3 RayBiotech BANK1 Antibody Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 RayBiotech Main Business Overview
11.7.5 RayBiotech Latest Developments
11.8 ProSci
11.8.1 ProSci Company Information
11.8.2 ProSci BANK1 Antibody Product Offered
11.8.3 ProSci BANK1 Antibody Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 ProSci Main Business Overview
11.8.5 ProSci Latest Developments
11.9 Novus Biologicals
11.9.1 Novus Biologicals Company Information
11.9.2 Novus Biologicals BANK1 Antibody Product Offered
11.9.3 Novus Biologicals BANK1 Antibody Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Novus Biologicals Main Business Overview
11.9.5 Novus Biologicals Latest Developments
11.10 ABclonal Technology
11.10.1 ABclonal Technology Company Information
11.10.2 ABclonal Technology BANK1 Antibody Product Offered
11.10.3 ABclonal Technology BANK1 Antibody Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 ABclonal Technology Main Business Overview
11.10.5 ABclonal Technology Latest Developments
11.11 R and D Systems
11.11.1 R and D Systems Company Information
11.11.2 R and D Systems BANK1 Antibody Product Offered
11.11.3 R and D Systems BANK1 Antibody Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 R and D Systems Main Business Overview
11.11.5 R and D Systems Latest Developments
11.12 United States Biological
11.12.1 United States Biological Company Information
11.12.2 United States Biological BANK1 Antibody Product Offered
11.12.3 United States Biological BANK1 Antibody Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 United States Biological Main Business Overview
11.12.5 United States Biological Latest Developments
11.13 Santa Cruz Biotechnology
11.13.1 Santa Cruz Biotechnology Company Information
11.13.2 Santa Cruz Biotechnology BANK1 Antibody Product Offered
11.13.3 Santa Cruz Biotechnology BANK1 Antibody Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Santa Cruz Biotechnology Main Business Overview
11.13.5 Santa Cruz Biotechnology Latest Developments
11.14 Biobyt
11.14.1 Biobyt Company Information
11.14.2 Biobyt BANK1 Antibody Product Offered
11.14.3 Biobyt BANK1 Antibody Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Biobyt Main Business Overview
11.14.5 Biobyt Latest Developments
11.15 Beijing Solarbio
11.15.1 Beijing Solarbio Company Information
11.15.2 Beijing Solarbio BANK1 Antibody Product Offered
11.15.3 Beijing Solarbio BANK1 Antibody Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Beijing Solarbio Main Business Overview
11.15.5 Beijing Solarbio Latest Developments
11.16 Jingjie PTM BioLab
11.16.1 Jingjie PTM BioLab Company Information
11.16.2 Jingjie PTM BioLab BANK1 Antibody Product Offered
11.16.3 Jingjie PTM BioLab BANK1 Antibody Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 Jingjie PTM BioLab Main Business Overview
11.16.5 Jingjie PTM BioLab Latest Developments
12 Research Findings and Conclusion